Gastric inhibitory polypeptide (GIP) is selectively decreased in the roux-limb of dietary obese mice after RYGB surgery.
Gastric inhibitory polypeptide (GIP, glucose-dependent insulinotropic polypeptide) is expressed by intestinal K cells to regulate glucose-induced insulin secretion. The impact of Roux-en Y bypass (RYGB) surgery on blood GIP is highly contraversial. This study was conducted to address the mechanism o...
Main Authors: | Jiaqiang Zhou, Zheng Hao, Nigel Irwin, Hans-Rudolf Berthoud, Jianping Ye |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4534413?pdf=render |
Similar Items
-
Gastric inhibitory polypeptide (GIP) decreases bone resorptive activity of human osteoclasts in vitro
by: Morten Steen Svarer Hansen, et al.
Published: (2021-04-01) -
Limb length in bariatric surgery of Roux-en-Y gastric bypass (RYGB): An integrative review
by: Bruno Landal Cavassin, et al.
Published: (2021-06-01) -
The aberrant expression of the gastric inhibitory polypeptide (GIP) receptor in adrenal hyperplasia: does chronic adrenocorticotropin exposure stimulate up-regulation of GIP receptors in Cushing's disease?
by: Swords, F, et al.
Published: (2005) -
Development and verification of a mouse model for Roux-en-Y gastric bypass surgery with a small gastric pouch.
by: Zheng Hao, et al.
Published: (2013-01-01) -
Binge Eating (BE) and Obesity: Brain Activity and Psychological Measures before and after Roux-En-Y Gastric Bypass (RYGB)
by: Shaunte Baboumian, et al.
Published: (2023-08-01)